Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Richard Adcock / Hagens Berman

Richard Adcock & Hagens Berman

2 shared events · Importance 3 · Last updated May 27, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
55
Regulatory
ImmunityBio Faces Securities Fraud Lawsuits
Richard Adcock: Richard Adcock is the CEO of ImmunityBio and was the recipient of the FDA's warning letter regarding the misleading promotion of Nogapendekin alfa inbakicept.
Hagens Berman: Hagens Berman is investigating claims that ImmunityBio violated federal securities laws and is urging investors with significant losses to join their class action lawsuit.
Apr 02, 2026 · 132 articles
0
Business
ImmunityBio Faces Anktiva Misrepresentation Lawsuits
Apr 01, 2026 · 64 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Richard Adcock and Hagens Berman interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.